Immune System Therapeutics
Sydney
About Immune System Therapeutics
Immune System Therapeutics Ltd (IST) is an unlisted public company limited by shares which was incorporated in Australia in 2001. Their mission is to develop and commercialise Mab technology for the treatment of blood cancers and other blood disorders.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $700.0K
- Last round: Series Unknown (Mar 2005)
- Website: istl.com.au
- Phone: 61 2 9514 7437
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immune-system-therapeutics-2084074 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.